About Dr. Hemant B. Tongaonkar
Dr. Hemant B. Tongaonkar is one of India’s most eminent surgical oncologists with over 35 years of dedicated service in the field of cancer care. Internationally recognized for his pioneering work in urologic and genitourinary oncology, he has treated thousands of complex cases involving kidney, bladder, prostate, and testicular cancers. Dr. Tongaonkar is also known for his deep expertise in pelvic exenteration and retroperitoneal tumors, making him a preferred choice for high-risk surgical interventions. He combines clinical excellence with a patient-first approach, emphasizing safety, precision, and long-term survivorship outcomes.
- MBBS – Grant Medical College, Mumbai MS (General Surgery) – Mumbai University
- Surgical Oncology Training – Tata Memorial Hospital, Mumbai
- Observership – Memorial Sloan Kettering Cancer Center, USA
- Life Member – Indian Association of Surgical Oncology (IASO)
- Fellow – International College of Surgeons
- Former President – Urological Society of India (Oncology Chapter)
- Kidney Cancer
- Bladder Cancer
- Prostate Cancer
- Testicular Cancer
- Urologic Oncology
- Retroperitoneal Tumor Excision
- Complex Pelvic Surgeries
- Radical Cystectomy with Neobladder Reconstruction
- Nerve-Sparing Radical Prostatectomy
- Retroperitoneal Lymph Node Dissection
- Total Pelvic Exenteration
- Nanavati Max Hospital, Mumbai – Senior Consultant
- Tata Memorial Hospital – Former Professor & Chief of Urologic Oncology
- Jaslok Hospital – Visiting Consultant
- Former Professor, Tata Memorial Centre
- Faculty Member, National Oncology Surgical Conferences
- Among the first in India to perform neobladder surgeries with excellent functional outcomes
- Mentor to numerous practicing uro-oncologists across India
- Lifetime Achievement Award – Tata Memorial Centre
- Oncologist of the Year – Maharashtra Medical Council, 2018
- Padma Shri Nominee for Services in Oncology
- “Functional Outcomes after Neobladder in Bladder Cancer Patients” – IJU, 2019
- “Surgical Approach to Retroperitoneal Tumors: 25-Year Experience” – ASCO Abstract
- Contributing Author – Urologic Oncology Textbook, Tata Memorial Series
Mr. Sanjay D., Prostate Cancer Survivor
- “Thanks to Dr. Tongaonkar, I recovered not just physically but emotionally. His confidence gave me the strength to fight cancer.”
Mrs. Alka P., Bladder Cancer Survivor
- “The neobladder surgery changed my life. I live a normal life again because of Dr. Hemant’s expertise.”
- Strong focus on personalized treatment plans, functional outcomes, and quality of life post-surgery.
- Extensive use of nerve-sparing techniques, 3D imaging for surgical planning, and post-operative rehabilitation pathways for urologic cancer patients.
Procedure | Estimated Cost (INR) | Estimated Cost (USD) |
Radical Cystectomy with Neobladder | ₹4,50,000 – ₹6,50,000 | $5,420 – $7,830 |
Radical Prostatectomy | ₹3,50,000 – ₹5,00,000 | $4,210 – $6,020 |
Retroperitoneal Tumor Excision | ₹3,80,000 – ₹5,50,000 | $4,570 – $6,630 |
Total Pelvic Exenteration | ₹5,00,000 – ₹7,00,000 | $6,020 – $8,430 |
- English, Hindi, Marathi (Interpreters available for Arabic, Russian, and French)
- Assistance with visa invitation letters, flight planning, accommodation, and airport pickup
- Available via Zoom and Microsoft Teams for international and long-distance patients